PFSA NASDAQ
Profusa, Inc. Common Stock
1W: -22.5%
1M: -36.7%
3M: -40.7%
YTD: -77.5%
1Y: +448.0%
$1.69
-0.18 (-9.63%)
Weekly Expected Move ±41.1%
$0
$1
$2
$2
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider+$0.0M
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.9M
52W Range1.58-3000
Volume359,585
Avg Volume1,925,745
Beta0.47
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJack E. Stover
Employees2
SectorHealthcare
IndustryMedical - Devices
IPO Date2025-07-14
Websiteprofusa.com
626 Bancroft Way, Suite A
Berkeley, CA 94710
US
Berkeley, CA 94710
US
415 655 9861
About Profusa, Inc. Common Stock
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Latest News
Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October
Profusa clears Nasdaq compliance issues
Profusa, Inc. reports Q2 results
Profusa to implement 1-for-4 reverse stock split
Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| STOVER JACK E | J-Other | 32,018 | — | 2026-08-21 |
| STOVER JACK E | J-Other | 301,991 | — | 2026-08-21 |
| Knechtel Fred S. | J-Other | 54,323 | — | 2026-08-21 |
| Knechtel Fred S. | J-Other | 301,991 | — | 2026-08-21 |
| HRT FINANCIAL LP | S-Sale | 18,395 | $5.94 | 2026-08-17 |